Meta-Analysis
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 7, 2014; 20(29): 10174-10182
Published online Aug 7, 2014. doi: 10.3748/wjg.v20.i29.10174
Figure 3
Figure 3 Comparison of adverse events and 1-, 2-, and 3-year overall survival rates between percutaneous ethanol injection and radiofrequency ablation for treatment of small hepatocellular carcinoma. A: Adverse events; B: 1-year overall survival rate; C: 2-year overall survival rate; D: 3-year overall survival rate. All analyses used the Mantel-Haenszel method.